Tissue reinforcement materials used in surgical sutures

By using multiple fibrous tissue reinforcement materials in surgical staplers to compress and seal around the fastening components, the problems of leakage and inflammation during surgical suture are solved, and the sealing performance and healing effect are improved.

CN113907821BActive Publication Date: 2024-11-15CILAG GMBH INTERNATIONAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111174967.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2013-11-08
Filing Date
2014-10-28
Publication Date
2024-11-15
Estimated Expiration
2034-10-28

AI Technical Summary

Technical Problem

Existing surgical staplers are prone to leakage and inflammation during use, and the implanted objects lack the natural flexibility and sealing properties of the tissue.

Method used

Using peelable tissue reinforcement materials, including multiple fibers, for compression and sealing around the fastening component, combined with the staple cartridge assembly and anvil of the surgical stapler, delivering the material to the tissue by deploying the staples to form a sealing effect.

Benefits of technology

Effectively reduces leakage and inflammation, maintains the natural properties of the tissue, and improves sealing properties, promoting the healing process.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113907821B_ABST
    Figure CN113907821B_ABST
Patent Text Reader

Abstract

The present invention provides tissue reinforcement materials used with end effectors such as surgical suturing devices, and methods associated with the operation of such end effectors. In an exemplary embodiment, the tissue reinforcement material is retained on a part of the surgical stapler end effector in a releasable manner for delivery to tissue when nails are deployed. The tissue reinforcement material comprises a plurality of fibers, which have an arrangement configured to be able to compress and seal around a fastening component inserted through the tissue reinforcement material. The present invention also provides other implants, devices and methods for surgical suturing.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of an international application entering the Chinese national phase, with an application date of October 28, 2014, international application number PCT / US2014 / 062504, national application number 201480061194.4, and title “Sealing material for use in surgical sutures”. Technical Field

[0002] The present invention relates to surgical instruments and, more particularly, to methods, devices, and components thereof for cutting and stapling tissue. Background Art

[0003] Surgical staplers are used in surgical procedures to close tissue, blood vessels, catheters, shunts, or other objects or body parts involved in a particular procedure. The openings may be naturally present, such as passages in internal organs such as blood vessels or the stomach, or they may be formed by a surgeon during surgery, such as by puncturing tissue or blood vessels to form a bypass or anastomosis or by cutting tissue during a suturing procedure.

[0004] Most staplers have a handle having an elongated shaft having a pair of movable opposing jaws formed on the ends thereof for holding and forming staples between the jaws. The staples are usually contained in a staple cartridge that can accommodate multiple rows of staples and is often disposed in one of the two jaws for pushing the staples to the surgical site. In use, the jaws are positioned so that the object to be sutured is disposed between the jaws, and the staples are ejected and formed when the jaws are closed and the device is actuated. Some staplers include a blade that is configured to travel between the rows of staples in the staple cartridge to longitudinally cut and / or open the sutured tissue between the suture rows.

[0005] Although surgical staplers have been improved over the years, they still have many problems of their own. A common problem is that leakage may occur because the staples form holes when piercing the tissue or other objects in which they are arranged. Even after the staples are fully formed, blood, air, gastrointestinal fluids, and other fluids may seep out through the openings formed by the staples. The treated tissue may also become inflamed due to the wounds caused by suturing. In addition, staples and other objects and materials that can be implanted in conjunction with surgeries such as suturing generally lack some characteristics of the tissues in which they are implanted. For example, staples and other objects and materials may lack the natural flexibility of the tissues in which they are implanted. Those skilled in the art will recognize that it is often desirable to maintain as much of its natural characteristics as possible after the staples are arranged therein.

[0006] In some cases, biomaterials have been used in conjunction with tissue suturing. However, the use of biomaterials can present a number of problems. For example, biologics can lack desirable mechanical properties such as the ability to seal around fastening components (e.g., surgical staples) inserted through the tissue reinforcement material. Biologics can also lack the ability to adequately reinforce tissue at the surgical site and / or address bleeding or fluid at the surgical site.

[0007] Thus, a need remains for improved devices and methods for suturing tissue, vessels, catheters, shunts, or other objects or body parts that minimize leakage and inflammation while substantially maintaining the natural properties of the treatment area. Summary of the invention

[0008] In various aspects and embodiments, the present disclosure provides implantable materials for use with end effectors such as surgical stapling devices, and methods associated with the operation of such end effectors.

[0009] In one aspect, the present disclosure provides a tissue reinforcement material that is retained in a releasable manner on a portion of a surgical stapler end effector for delivery to tissue when deploying staples. The tissue reinforcement material includes a plurality of fibers having an arrangement configured to compress and seal around a fastening component inserted through the tissue reinforcement material.

[0010] In another aspect, the present disclosure provides a staple cartridge assembly for use with a surgical stapler. The assembly includes a cartridge body having a plurality of staple cavities configured to accommodate staples therein. The assembly also includes a tissue reinforcement material that is retained on the cartridge body in a removable manner and is configured to be delivered to the tissue by deploying the staples in the cartridge body. The tissue reinforcement material includes a plurality of fibers that have an arrangement configured to compress and seal around a fastening component inserted through the tissue reinforcement material.

[0011] On the other hand, the present disclosure provides a method for implanting a tissue reinforcement material. The method includes engaging tissue between a cartridge assembly and an anvil of a surgical stapler at a surgical site. At least one of the cartridge assembly and the anvil has a tissue reinforcement material held thereon in a releasable manner. The material includes a plurality of fibers having an arrangement capable of compressing and sealing around a fastening component inserted through the tissue reinforcement material. The method also includes actuating the surgical stapler to inject a staple from the cartridge assembly into the tissue, the fastening component extending through the tissue reinforcement material to hold the material at the surgical site and forming a seal around the fastening component.

[0012] In various embodiments, the present disclosure contemplates combining all of the functionalities of the above aspects with any one or more of the following features (in addition to the other aspects and embodiments described herein).

[0013] In various embodiments, a portion of a surgical stapler end effector includes at least one of a staple cartridge and an anvil.

[0014] In various embodiments, the arrangements are braided and loop structures.

[0015] In various embodiments, the arrangement is also configured to enable the material to stretch and recover in response to penetration of the fastening component.

[0016] In various embodiments, the plurality of fibers are elastic.

[0017] In various embodiments, the material comprises a biological material.

[0018] In various embodiments, the plurality of fibers comprises a biological material. In various embodiments, the plurality of fibers comprises a synthetic material. In some embodiments, the plurality of fibers comprises a biological material and a synthetic material.

[0019] In various embodiments, the material has a single layer comprising a plurality of fibers.

[0020] In various embodiments, the material has a single layer including the biomaterial and the plurality of fibers.

[0021] In various embodiments, the material has a first layer comprising a biomaterial and a second layer comprising a plurality of fibers.

[0022] In various embodiments, the material is a hybrid secondary material including biological and synthetic materials.

[0023] In various embodiments, the material expands around the fastening component when the fastening component is inserted through it to form a seal around the fastening component. In various embodiments, the material expands around the fastening component when the second material is wetted to form a seal around the fastening component. In some embodiments, the material expands around the fastening component when the fastening component is inserted through it and when the material is wetted to form a seal around the fastening component.

[0024] In various embodiments, the material engages the fastening components as they are inserted therethrough to mitigate movement of material and tissue adjacent the fastening components relative to the fastening components.

[0025] In various embodiments, the fastening components include staple legs.

[0026] In various embodiments, the material further comprises a staple cartridge attached thereto.

[0027] In various embodiments, the material is bioimplantable and bioresorbable.

[0028] In various embodiments, the assembly includes at least one retaining member configured to couple the material to the bin body. The at least one retaining member may be coupled to an outer edge of the bin body and an outer edge of at least one of the biological tissue membrane and the synthetic substrate layer. The at least one retaining member may include a suture. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] The present invention may be more fully understood according to the following specific embodiments in conjunction with the accompanying drawings, in which:

[0030] Figure 1 is a perspective view of an exemplary embodiment of a surgical instrument having an attachment portion attached to a distal end thereof;

[0031] Figure 2 for Figure 1 A perspective view of a surgical instrument with the attachment portion disengaged from the shaft of the instrument;

[0032] Figure 3 for Figure 2 A perspective view of an attachment portion of the embodiment of the present invention, the attachment portion comprising at least one piece of auxiliary material;

[0033] Figure 4 for Figure 3 An exploded perspective view of an end effector of , wherein auxiliary materials have been removed;

[0034] Figure 5 For Figure 4 A detailed perspective view of the distal end of a staple cartridge used with an end effector;

[0035] Figure 6 For along Figure 5 A side cross-sectional view taken along the section line shown in ;

[0036] Figure 7 for Figure 5 A bottom perspective view of a nail magazine;

[0037] Figure 8 for Figure 4 Detailed perspective view of an actuation slide, pusher and fastener of a surgical instrument;

[0038] Fig. 9 is a perspective view of another exemplary embodiment of an attachment portion for use in a surgical instrument;

[0039] Fig.10 for Fig. 9 An exploded perspective view of the end effector of the attachment portion;

[0040] Fig.11 For Figure 4 an exploded view of a drive assembly for use with an end effector;

[0041] Fig.12 for Figure 3 A perspective view of a lower jaw of an end effector;

[0042] Fig.13 for Figure 3 A perspective view of an upper jaw of an end effector of the invention, the upper jaw having auxiliary material associated therewith;

[0043] Fig.14 for Figure 2 a perspective view of a portion of an end effector of the invention, the portion comprising a retaining member configured to releasably retain an auxiliary material;

[0044] Fig.15 for Fig.10 A perspective view of a lower jaw of an end effector;

[0045] Fig.16 An end effector having a tissue reinforcement material having a plurality of fibers arranged in a loop structure is shown.

[0046] Fig.16A for Fig.16 Detailed view of a portion of a tissue augmentation material.

[0047] Fig. 16B For forming Fig.16 Schematic diagram of a portion of a tissue reinforcement material's fiber strands.

[0048] Fig. 16C for Fig. 16B Cross-sectional view of the fiber strands at section AA.

[0049] Fig.17A and 17B An exploded view of an exemplary tissue reinforcement material is shown having a plurality of fibers arranged in a loop structure as shown, which is compressed and sealed around a fastening component.

[0050] Fig.18 Another exemplary embodiment of a tissue reinforcement material having vertical elasticity and radial elasticity is shown.

[0051] Fig.19 A perspective view of an end effector with an alternative exemplary tissue reinforcement material having a collagen matrix that can be sealed around a fastening component is shown.

[0052] Fig. 20 and 21 Shows the passage through the tissue and Fig.19 An exploded cross-sectional view of an exemplary fastener of a tissue reinforcement material.

[0053] Fig. 22 A portion of tissue is shown having a sutured portion and a portion having an exemplary hybrid auxiliary tissue augmentation material after deployment in the tissue.

[0054] Fig.23A is an isometric view of an alternative exemplary tissue augmentation material including a surgical adhesive sealing around a fastening component.

[0055] Fig. 23B for Fig.23A Side view of a tissue augmentation material prior to being penetrated by a surgical staple.

[0056] Fig.23C for Fig. 23B Isometric view of a tissue augmentation material after being penetrated by a surgical staple.

[0057] Fig.24A is a cross-sectional view of opposing jaws of an end effector having another alternative exemplary tissue augmentation material.

[0058] Fig. 24B for Fig.24A Detailed view of the portion of the tissue reinforcement material on the jaws of the end effector.

[0059] Fig.24C for Fig.24A and 24B A perspective view of two tissue reinforcement material layers shown in FIG.

[0060] Fig.25A -C shows an exemplary method for implanting a tissue augmentation material. DETAILED DESCRIPTION

[0061] Certain exemplary embodiments will now be described to understand the structure, function, manufacture and use principles of the devices and methods disclosed herein as a whole. One or more examples in these embodiments are shown in the accompanying drawings. It should be understood by those skilled in the art that the devices and methods specifically described herein and shown in the accompanying drawings are non-restrictive exemplary embodiments, and the scope of the present invention is limited only by the claims. The characteristic structures illustrated or described in conjunction with an exemplary embodiment can be combined with the characteristic structures of other embodiments. Such modified forms and variant forms are intended to be included within the scope of the present invention. In addition, in the present disclosure, the same numbered parts of various embodiments generally have similar characteristic structures when they have similar properties and / or they serve similar purposes.

[0062] "Various embodiments", "some embodiments", "one embodiment" or "embodiment" etc. mentioned throughout this specification mean that the specific features, structures or characteristics described in conjunction with the embodiment are included in at least one embodiment. Therefore, the phrases "in various embodiments", "in some embodiments", "in one embodiment" or "in an embodiment" etc. appearing throughout this specification do not necessarily all refer to the same embodiment. In addition, in one or more embodiments, specific features, structures or characteristics may be combined in any suitable manner. Therefore, without limitation, the specific features, structures or characteristics shown or described in conjunction with one embodiment may be combined in whole or in part with the features, structures or characteristics of one or more other embodiments. Such modifications and variations are intended to be included within the scope of the present invention.

[0063] The terms "proximal" and "distal" as used herein are relative to a clinician manipulating the handle portion of a surgical instrument. The term "proximal" refers to the portion closest to the clinician, and the term "distal" refers to the portion positioned away from the clinician. It should also be understood that for the sake of brevity and clarity, spatial terms such as "vertical," "horizontal," "upper," and "lower" may be used herein in conjunction with the accompanying drawings. However, surgical instruments are used in many orientations and positions, and these terms are not restrictive and / or absolute.

[0064] Various exemplary devices and methods are provided for performing laparoscopic and minimally invasive surgical procedures. However, it should be appreciated by those skilled in the art that the various methods and devices disclosed herein can be used in many surgical procedures and applications. It should also be appreciated by those skilled in the art that the various instruments disclosed herein can be inserted into the body in any manner, such as through a natural cavity, through an incision or puncture formed in tissue, or through an access device (such as a cannula of a trocar). For example, the working portion or end effector portion of the instrument can be inserted directly into the patient's body or can be inserted through an access device having a working channel through which the end effector and elongated shaft of the surgical instrument can be advanced.

[0065] It is desirable that one or more biomaterials and / or synthetic materials (collectively referred to herein as "auxiliary materials") are used in conjunction with surgical instruments to help improve surgical procedures. Those skilled in the art may use these types of materials as support materials and auxiliary materials. Although a variety of different end effectors may benefit from the use of auxiliary materials, in some exemplary embodiments, the end effector may be a surgical stapler. When used in conjunction with a surgical stapler, the auxiliary material may be disposed between and / or on the jaws of the stapler, incorporated into a staple cartridge disposed in the jaws, or otherwise placed close to the staple. When the staple is deployed, the auxiliary material may be retained at the treatment location with the staple, thereby providing multiple benefits. In some cases, when the material is implanted into tissues, blood vessels, and various other objects or body parts, they may be used to help seal the holes formed by the staples. In addition, the material may be used to provide tissue enhancement at the treatment site. In addition, the material may help reduce inflammation, promote cell growth, and otherwise improve healing.

[0066] Some configurations of auxiliary materials include both synthetic materials and biomaterials. The combination of two types of materials can lead to the formation of hybrid auxiliary materials. When properly designed and / or selected, hybrid auxiliary materials can combine the beneficial features of synthetic materials and the beneficial features of biomaterials in a single hybrid auxiliary material. Therefore, when other desired biomaterials may lack the same desired mechanical (or other) properties, combining biomaterials with synthetic materials that provide mechanical (or other) properties can provide a hybrid auxiliary material with two desired properties. For example, hybrid auxiliary materials can be designed to combine the benefits of biomaterials (such as improving healing and tissue growth at the surgical site) with the desired mechanical properties of synthetic materials (such as the ability to compress and form a seal around a fastening component).

[0067] Surgical suture instruments

[0068] Although a variety of surgical instruments can be used in conjunction with the auxiliary materials disclosed herein, Figure 1 and 2Only one non-limiting exemplary embodiment of a surgical stapler 10 suitable for use with one or more auxiliary materials is shown. As shown, the instrument 10 includes a handle assembly 12, a shaft 14 extending distally from the distal end 12d of the handle assembly 12, and an attachment portion 16 removably connected to the distal end 14d of the shaft 14. Because the illustrated embodiment is a surgical stapler, the distal end 16d of the attachment portion 16 includes an end actuator 50 with jaws 52, 54, but other types of end actuators can be used with the shaft 14, the handle assembly 12, and the components associated therewith. As shown, the surgical stapler includes a first jaw 52 and a second jaw 54 relative to each other, wherein the first lower jaw 52 includes an elongated channel 56 ( Figure 4 ), and the second upper jaw 54 has an inner surface 58 ( Figure 3 , 4 and 6), the inner surface 58 faces the lower jaw 52 and is configured to operate as an anvil to facilitate the deployment of the nails in the nail magazine. The jaws 52, 54 are configured to move relative to each other to clamp tissue or other objects disposed therebetween, and the axial drive assembly 80 ( Fig.11 ) can be configured to pass through at least a portion of the end effector 50 to fire the staples into the clamped tissue. In various embodiments, the blade 81 can be associated with the axial drive assembly 80 to cut tissue during a stapling procedure.

[0069] The operation of the end effector 50 and the drive assembly 80 may begin with input from a clinician at the handle assembly 12. The handle assembly 12 may have many different configurations designed to regulate and operate the end effector associated therewith. In the illustrated embodiment, the handle assembly 12 has a pistol grip housing 18 having a plurality of mechanical components disposed therein to operate various features of the instrument. For example, the handle assembly 12 may include mechanical components as part of a firing system that is actuated by a trigger 20. The trigger 20 may be biased to an open position relative to the fixed handle 22, for example, by a torsion spring, and the movement of the trigger 20 toward the fixed handle 22 may actuate the firing system so that the axial drive assembly 80 passes through at least a portion of the end effector 50 and ejects the nail from the nail magazine disposed therein. Those skilled in the art will recognize various configurations of components of the firing system (mechanical or otherwise) that may be used to eject nails and / or cut tissue, and therefore, it is not necessary to explain these configurations in detail.

[0070] Other non-limiting examples of features that can be incorporated into the handle assembly 22 include a rotatable knob 24, an articulated rod 26, and a retraction knob 28, which affect the regulation and operation of the end effector associated therewith. As shown, the rotatable knob 24 can be mounted on the front end of the barrel portion 30 of the handle assembly 12 to facilitate the rotation of the shaft 14 (or the attachment portion 16) relative to the handle assembly 12, around the longitudinal axis L of the shaft 14. The actuating rod 26 can also be mounted on the front end of the barrel portion 30, generally adjacent to the rotatable knob 24. The rod 26 can be regulated from left to right along the surface of the barrel portion 30 to facilitate the interactive articulation of the end effector 50. One or more retraction knobs 28 can be movably positioned along the barrel portion 30 to, for example, return the drive assembly 80 to the retracted position after the firing system has completed the firing stroke. As shown, the retraction knob 28 is moved proximally toward the rear end of the barrel portion 30 to retract the components of the firing system (including the drive assembly 80).

[0071] Other non-limiting examples of the characteristic structures that can be incorporated into the handle assembly 22 include a firing lock assembly, an anti-reverse clutch mechanism, and an emergency return button, which affects the regulation and operation of the end effector associated therewith. The firing lock assembly can be configured to prevent the firing system from being actuated at an unexpected time, such as when the end effector is not fully connected to the instrument. The anti-reverse clutch mechanism can be configured to prevent the parts of the firing system from moving backward when such backward motion is not expected, such as when the firing stroke is only partially completed but temporarily stopped. The emergency return button can be configured to allow the parts of the firing system to retract before the firing stroke is completed, for example, when the completion of the firing stroke can cause tissue to be cut unexpectedly. Although characteristic structures such as the firing lock assembly, the anti-reverse clutch mechanism, and the emergency return button are not clearly shown in the instrument 10, those skilled in the art should recognize the various configurations of each characteristic structure that can be incorporated into the handle assembly and / or other parts of the surgical stapler without departing from the spirit of the present disclosure. Additionally, some exemplary embodiments of features that may be incorporated into the handle assembly 12 are provided in the patents and patent applications incorporated by reference anywhere in this application.

[0072] The shaft 14 can be removably coupled to the distal end 12d of the handle assembly 12 at the proximal end 14p of the shaft 14, and the distal end 14d of the shaft 14 can be configured to receive the attachment portion 16. As shown, the shaft 14 is generally cylindrical and elongated, but any number of shapes and configurations can be used for the shaft, which depends (at least in part) on the configuration of other instrument components used therewith and the type of surgery in which the instrument is used. For example, in some embodiments, the distal end of one shaft can have a specific configuration for receiving certain types of end effectors, while the distal end of another shaft can have a different configuration for receiving certain other types of end effectors. Components of the firing system such as the control rod 32 ( Figure 2 ) may be disposed in the shaft 14 so that the components are accessible to the end effector 50 and the drive assembly 80 to provide actuation of the end effector 50 and the drive assembly 80. For example, when the trigger 20 operates the firing system, the control rod 32 may be advanced distally through at least a portion of the shaft 14 to collapse the jaws 52, 54 toward each other and / or drive the drive assembly 80 distally through at least a portion of the end effector 50.

[0073] The shaft 14 may also include one or more sensors (not shown) and related components such as electronic components to facilitate operation and use of the sensors (not shown). The sensors and related components may be configured to be able to send the type of end effector associated with the distal end 14d of the shaft 14 to the clinician in addition to the parameters. Similarly, the handle assembly 12 may include one or more sensors and related components that are configured to be able to send the type of actuator and / or shaft associated with the distal end 12d of the handle assembly 12 to the clinician. Therefore, because multiple shafts can be interchangeably connected to the handle assembly 12 and multiple end effectors with different configurations can be interchangeably connected to each shaft, the sensor can help the clinician understand which shaft and end effector are being used. In addition, based on the type of shaft and end effector connected to the handle assembly, information from the sensor can help the monitoring or control system associated with the instrument understand which operation and measurement parameters are relevant to the clinician. For example, when the end effector is a stapler, information about the number of times the drive assembly 80 has been fired may be relevant, and when the end effector is another type of end effector such as a cutting device, the distance the cutting portion has traveled may be relevant. Based on the end effector being sensed, the system can convey appropriate information to the clinician.

[0074] Those skilled in the art will recognize that monitoring and control systems of various configurations can be used in conjunction with the surgical instruments provided herein. For example, sensors associated with any one of the end effector 50, the attachment portion 16, the shaft 14, and the handle assembly 12 can be configured to monitor other system parameters, and the monitoring or control system can send relevant other parameters to the clinician based on the type of shaft or attachment portion associated with the handle assembly. Additional details about sensors and related components and monitoring and control systems can be found in patents and patent applications incorporated by reference anywhere in this application.

[0075] like Figure 3 As shown, the attachment portion 16 may include a proximal housing portion 34 at its proximal end 16p and an end effector or tool 50 at its distal end 16d. In the illustrated embodiment, the proximal housing portion 34 includes an engagement block 36 on its proximal end 34p for releasably engaging the shaft 14. The block 36 forms a bayonet-type coupling with the distal end 14d of the shaft 14. In addition to the block 36, any number of other complementary mating features may be used to removably couple the attachment portion 16 to the shaft 14.

[0076] The distal end 34d of the proximal housing portion 34 may include a mounting assembly 40 pivotally secured thereto. Figure 4 As shown, the mounting assembly 40 can be configured to receive the proximal end 50p of the end effector 50 so that pivotal movement of the mounting assembly 40 about an axis perpendicular to the longitudinal axis of the housing portion 34 produces articulation of the end effector 50 about the pivot member or pin 42. This pivotal movement can be controlled by the actuation rod 26 of the handle assembly 28 and components disposed between the rod 26 and the mounting assembly 40 so that movement of the rod 26 articulates the mounting assembly 40 and thereby the end effector 50. Similar to the firing system of the instrument 10, those skilled in the art will recognize various configurations of components for producing articulation (mechanical or otherwise), and therefore it is not necessary to explain these configurations in detail. Some exemplary embodiments of components for producing articulation suitable for use with the disclosure herein are provided in the patents and patent applications incorporated by reference anywhere in this application.

[0077] The end effector 50 of the illustrated embodiment is a surgical stapling tool having a first lower jaw 52 that serves as a cartridge assembly or carrier and an opposing second upper jaw 54 that serves as an anvil. Figure 6As shown, the inner surface 58 of the second jaw 54 (sometimes also referred to as the anvil portion) may include a plurality of nail deformation cavities 60 and a cover plate 62 fixed to the top surface 59 of the jaws 54 to define a cavity 64 therebetween. The cover plate 62 may help prevent tissue contraction during the clamping and firing of the surgical stapler. The size of the cavity 64 may be designed to receive the distal end 80d of the axial drive assembly 80. The longitudinal slot 66 may extend through the anvil portion 58 to facilitate the fixed flange 82 of the axial drive assembly 80 to enter the anvil cavity 64. The cam surface 57 formed on the anvil portion 58 may be positioned to engage the axial drive assembly 80 to facilitate clamping tissue 99. A pair of pivot members 53 formed on the anvil portion 54 may be positioned in the slot 51 formed in the carrier 52 to guide the anvil portion between the open position and the clamped position. A pair of stabilizing members can engage corresponding shoulders 55 formed on the carrier 52 to prevent the anvil portion 54 from sliding axially relative to the staple cartridge 100 when the cam surface 57 is deformed. In other embodiments, the carrier 52 and staple cartridge 100 can pivot between the open position and the clamped position while the anvil portion 54 remains substantially stationary.

[0078] The elongated support channel 56 of the first jaw 52 can be sized and configured to receive a staple cartridge 100, such as Figure 4 , 5 and 7. Corresponding tabs 102 and slots 68 formed along the staple cartridge 100 and the elongated support channel 56, respectively, are used to retain the staple cartridge 100 within the support channel 56. A pair of support posts 103 formed on the staple cartridge 100 can be positioned to rest on the side walls of the carrier 52 to further stabilize the staple cartridge 100 within the support channel 56. The staple cartridge 100 can also include a retaining slot 105 for receiving a plurality of fasteners 106 and a pusher 108. A plurality of spaced longitudinal slots 107 can extend through the staple cartridge 100 to accommodate a firing system ( Figure 4 and 8 ) of the actuating slide 72. The central longitudinal slot 109 can extend along the length of the staple cartridge 100 to facilitate the passage of the blade 81 associated with the axial drive assembly 80. During the operation of the surgical stapler, the actuating slide 72 translates through the longitudinal slot 107 of the staple cartridge 100 to advance the cam wedge 70 into continuous contact with the pusher 108, thereby causing the pusher 108 to translate vertically within the retaining slot 105 and push the fastener 106 from the slot 105 into the staple deformation cavity 60 of the anvil portion 54.

[0079] Fig. 9 and Fig.10An alternative embodiment of the attachment portion 16' is shown. The attachment portion 16' may include a proximal housing portion 34' at its proximal end 16p' and an end effector or tool 50' at its distal end 16d'. A block 36' may be provided to removably couple the attachment portion 16' to the shaft of the surgical instrument, and a mounting assembly 40' may be provided to removably and / or pivotally couple the end effector or tool 50' to the proximal housing portion 34'. The end effector 50' may include a first lower jaw 52' that serves as a cartridge assembly and a second upper jaw 54' that serves as an anvil portion. The first jaw 52' may have a plurality of Figure 3 , 4 The same features as the first jaw 52 of 6 may therefore include an elongated support channel 56' and a slot 68', the elongated support channel 56' being sized and configured to receive a staple cartridge 100', the slot 68' being configured to correspond with the tab 102' of the staple cartridge 100' to retain the cartridge 100' within the channel 56'. Similarly, the cartridge 100' may include a support post 103' resting on the side wall of the jaw 52', a retaining slot 105' for receiving a plurality of fasteners 106' and a pusher 108', a plurality of spaced apart longitudinal slots 107' for accommodating an upright cam wedge 70' of an actuating slide 72' of a firing system, and a central longitudinal slot 109' facilitating passage of a blade 81' associated with an axial drive assembly 80'.

[0080] and Figure 3 , 4 Similar to the second jaw 54 of 6, the second jaw 54' may include a cover plate 62' fixed to the top surface of the jaws to define a cavity therebetween. The anvil plate 58' may serve as the inner surface of the jaws 54' and may include a longitudinal slot 66' for receiving the distal end of the axial drive assembly 80', and a plurality of nail deformation pits or cavities (not shown) for forming nails ejected from the magazine 100'. However, in this embodiment, the magazine 100' containing the lower jaw 52' is configured to be able to pivot to the upper jaw 54' while the upper jaw 54' remains substantially stationary after being actuated by the handle assembly and related components.

[0081] The end effector and the staple cartridge disposed therein are configured to receive an axial drive assembly. Fig.11 80. As shown, the distal end of the drive beam 84 can be defined by a vertical support column 86 supporting a blade 81 and an abutment surface 88, which is configured to engage the central portion of the actuation slide 72 during a stapling procedure. The bottom surface 85 at the base of the abutment surface 88 can be configured to receive a staple cartridge 100 ( Figure 4 and 6) is slidably positioned at the bottom of the support member 87. The blade 81 can be positioned to translate slightly behind the actuating slide 72 through the central longitudinal slot 109 in the staple cartridge 100 to form an incision between the rows of stapled body tissue. The retaining flange 82 can protrude distally from the vertical support column 86 and can support a cylindrical cam roller 89 at its distal end. The cam roller 89 can be sized and configured to engage the cam surface 57 on the anvil portion 58 to clamp the anvil portion 58 against body tissue. Those skilled in the art will recognize that the drive assembly used in conjunction with a surgical stapler or other surgical instrument can have many Fig.11 , some of which are described in the patents and patent applications incorporated by reference anywhere in this application. By way of non-limiting example, drive assembly 80 may include a single drive beam or any other number of drive beams, and the distal end of the drive beam may have any number of shapes configured to be used in an end effector through which the drive assembly is configured to travel.

[0082] In use, the surgical stapler can be arranged in a sleeve or a mouth and is arranged at the surgical site. The tissue to be cut and sutured can be placed between the jaws 52,54 of the surgical stapler 10. The characteristic structure 10 of the stapler 10, such as the rotating knob 24 and the actuating rod 26, can be mobilized according to the needs of the clinician so that the jaws 52,54 at the surgical site and the tissue relative to the jaws 52,54 achieve the desired position. After achieving appropriate positioning, the trigger 20 can be pulled toward the fixed handle 22 to actuate the firing system. The trigger 20 can cause the parts of the firing system to operate in the following manner: the control rod 32 is advanced toward the distal side through at least a portion of the shaft 14 so that at least one of the jaws 52,54 collapses toward another to clamp the tissue disposed therebetween and / or drive the drive assembly 80 toward the distal side through at least a portion of the end effector 50.

[0083] In some embodiments, a first firing of the trigger 20 can cause the jaws 52, 54 to clamp tissue, while subsequent firings of the trigger 20 can cause the drive assembly 80 to be advanced distally through at least a portion of the end effector 50. A single subsequent firing can fully advance the drive assembly 80 through the staple cartridge 100 to eject the rows of staples, or alternatively, the components in the handle assembly 12 can be configured such that multiple subsequent firings are required to fully advance the drive assembly 80 through the staple cartridge 100 to eject the rows of staples. Any number of subsequent firings may be required, but in some exemplary embodiments, anywhere from two to five firings can fully advance the drive assembly 80 through the staple cartridge 100. In embodiments where the drive assembly 80 includes a blade 81 to cut stapled tissue, the blade 81 cuts tissue as the drive assembly is advanced distally through the end effector 50 and thereby through the staple cartridge 100 disposed therein. In other exemplary embodiments, a motor disposed within the handle assembly 12 and associated with the firing trigger can automatically actuate the drive assembly 80 in response to activation of the firing trigger.

[0084] When the drive assembly 80 has been advanced to the distal side through the staple cartridge 100, the retraction knob 28 can be advanced to the proximal side to retract the drive assembly 80 back toward its initial position. In some configurations, before the assembly 80 is fully advanced through the cartridge 100, the retraction knob 28 can be used to retract the drive assembly 80. In other embodiments, after a predetermined action, the retraction of the drive assembly 80 can occur automatically. For example, once the drive assembly 80 has been advanced to its desired position toward the distal side, the trigger 80 is subsequently returned back to the biased open position and the drive assembly 80 can be automatically retracted. The drive assembly 80 can be retracted using a motor and associated components rather than the retraction knob 28 and associated components. In addition, as will be appreciated by those skilled in the art, other characteristic structures such as firing locking mechanisms, anti-reverse clutch mechanisms, and emergency return buttons as discussed above can be relied upon during the operation of the surgical stapler 10.

[0085] The illustrated embodiment of the surgical stapling instrument 10 provides one of many different configurations and related methods of use that can be used in conjunction with the disclosure provided herein. Additional exemplary embodiments of surgical staplers, components thereof, and related methods of use thereof that can be used according to the present disclosure include those provided in U.S. Patent Application Publication Nos. 2012 / 0083835 and 2013 / 0161374, each of which is incorporated herein by reference in its entirety.

[0086] Implantable Materials

[0087] Regardless of the configuration of the surgical instrument, the present disclosure provides implantable materials, such as biological materials and / or synthetic materials, collectively referred to as "adjunct materials," for use in conjunction with instrumentation. Fig.12 and 13 As shown, the end actuator 50 may include at least one piece of auxiliary material 200, 200' positioned between the first jaw member 52 and the second jaw member 54, and the auxiliary material can be releasably retained to one of the support channel 56 and / or the anvil portion 58. In the illustrated embodiment, the releasable retention is provided by the retaining members 202, 202' described in further detail below. In at least one embodiment, the surface on the auxiliary material 200, 200' can be configured to contact the tissue when the tissue is clamped between the first jaw member 52 and the second jaw member 54. In such an embodiment, the auxiliary material can be used to distribute the compressive clamping force over the tissue, remove excess fluid from the tissue, and / or improve the grip of the nail. In various embodiments, one or more pieces of auxiliary material can be positioned within the end actuator 50. In at least one embodiment, a piece of auxiliary material 200 can be attached to the nail magazine 100 ( Fig.12 ), and a piece of auxiliary material 200' may be attached to the anvil portion 58 ( Fig.13 In at least one other embodiment, for example, two pieces of auxiliary material 200 can be positioned on the support channel 56, and one piece of auxiliary material 200' can be positioned on the anvil portion 58. Any suitable number of auxiliary materials can be positioned within the end effector 50.

[0088] The auxiliary material used in combination with the disclosure provided herein can have any number of structures and performances. Generally speaking, they can be formed by, for example, bioabsorbable materials, biodegradable materials, and / or materials that can be decomposed in other ways, so that the auxiliary material can be absorbed, degraded and / or decomposed during healing. In at least one embodiment, the auxiliary material can include therapeutic drugs, which can, for example, be released over time to help tissue healing. In other various embodiments, the auxiliary material can include, for example, non-absorbable materials and / or materials that cannot be decomposed. Similarly, connecting or retaining members can be formed at least in part by at least one of bioabsorbable materials, biodegradable materials, and materials that can be decomposed, so that connecting members or retaining members can be absorbed, degraded and / or decomposed in the body. In various embodiments, connecting or retaining members can include therapeutic drugs, which can, for example, be configured to release over time to help tissue healing. In other various embodiments, connecting or retaining members can include, for example, non-absorbable materials and / or materials that cannot be decomposed such as plastics.

[0089] More specifically, some illustrative, non-limiting examples of synthetic materials that can be used in conjunction with the disclosure provided herein include biodegradable, absorbable synthetic polymers such as those sold under the trade names The biodegradable films include polydioxanon films or polyglycerol sebum (PGS) films sold under the trade name Vicryl, PCL (polycaprolactone), PLA or PLLA (polylactic acid), PHA (polyhydroxyalkanoate), PGCL (polycaprone 25, sold under the trade name Monocryl), PANACRYL (Ethicon, Inc., Somerville, NJ), polylactic-co-glycolic acid 910 (Polyglactin 910), polyglycolic acid carbonate, PGA / TMC (polyglycolic acid-trimethylene carbonate sold under the trade name Biosyn), polyhydroxybutyrate (PHB), poly(vinyl pyrrolidone) (PVP), poly(vinyl alcohol) (PVA), or copolymeric mixtures of PGA, PCL, PLA, PDS monomers. In use, the synthetic material can be decomposed by exposure to water so that the water erodes the polymer bonds of the synthetic material. As a result, the mechanical strength may weaken, and the construction of the material may decompose into a mushy or broken scaffold. As further decomposition occurs that decomposes the material into carbohydrates and acidic components, the patient's body may metabolize and excrete the decomposed material.

[0090] Some illustrative, non-limiting examples of bio-source materials that can be used in conjunction with the disclosure provided herein include platelet-poor plasma (PPP), platelet-rich plasma (PRP), starch, chitosan, alginate, fibrin, thrombin, polysaccharides, cellulose, collagen, bovine collagen, bovine pericardium, gelatin-resorcinol-formalin adhesive, oxidized cellulose, shellfish-based adhesive, poly(amino acids), agarose, polyetheretherketone, starch sugar, hyaluronan, hyaluronic acid, whey protein, cellulose gum, starch, gelatin, silk, or other materials (including combinations of materials) suitable for mixing with biomaterials and being introduced into wounds or defect sites, or any material that is clear to those skilled in the art based on the disclosure provided herein. Biomaterials can be derived from many sources, including derived from patients in which biomaterials are implanted, humans who are not patients in which biomaterials are implanted, or other animals.

[0091] Additional disclosures related to synthetic or polymeric materials and biomaterials that can be used in conjunction with the disclosure provided herein can be found in the following patents: U.S. Patent Application Publication No. 2012 / 0080335, U.S. Patent Application Publication No. 2012 / 0083835, U.S. Patent Application Serial No. 13 / 433,115, entitled “Tissue Thickness Compensator Comprising Capsules Defining a Low Pressure Environment” and filed on March 28, 2012, U.S. Patent Application Serial No. 13 / 433,118, entitled “Tissue Thickness Compensator Comprised of a Plurality of Materials” and filed on March 28, 2012, U.S. Patent Application Serial No. 13 / 532,825, entitled “Tissue Thickness Compensator Having Improved Visibility” and filed on June 26, 2012, U.S. Patent Application Serial No. 13 / 532,825, entitled “Electrosurgical End Effector with Tissue Tacking No. 13 / 710,931, filed on December 11, 2012, entitled “Features” and U.S. patent application serial number 13 / 763,192, filed on February 8, 2013, entitled “Multiple Thickness Implantable Layers for Surgical Stapling Devices,” each of which is incorporated herein by reference in its entirety.

[0092] In use, the auxiliary material may be preloaded onto the device and / or the staple cartridge, while in other cases the auxiliary material may be packaged separately. In the case where the auxiliary material is preloaded onto the device and / or the staple cartridge, the suturing operation may be performed as known to those skilled in the art. For example, in some cases, the firing of the device may be sufficient to separate the auxiliary material from the device and / or the staple cartridge, thereby eliminating the need for additional action by the clinician. In other cases, before the instrument is removed from the surgical site, any residual connection or retaining member that combines the auxiliary material with the device and / or the staple cartridge may be removed, thereby leaving the auxiliary material at the surgical site. In the case where the auxiliary material is packaged separately, the material may be releasably connected to at least one of the components of the end effector and the staple cartridge before firing the device. The auxiliary material may be refrigerated, and thereby removed from the refrigerator and associated packaging, and then connected to the device using a connection or retaining member as described herein or in other ways known to those skilled in the art. The suturing operation may then be performed as known to those skilled in the art, and if necessary, the auxiliary material may be separated from the device as described above.

[0093] Keep components

[0094] A connecting or retaining member may be used to secure one or more pieces of auxiliary material (at least temporarily) to the end effector and / or staple cartridge. These retaining members may have a variety of forms and configurations, such as one or more sutures, adhesive materials, staples, brackets, snap-on or other connecting or mating elements, and the like. For example, a retaining member may be positioned proximate to one or more sides and / or ends of the auxiliary material, which may help prevent the auxiliary material from being released from the staple cartridge and / or anvil surface when the end effector is inserted through a trocar or engaged with tissue. In other embodiments, the retaining member may be used with or in the form of an adhesive suitable for retaining the auxiliary material to the end effector in a releasable manner, such as cyanoacrylate. In at least one embodiment, an adhesive may be applied to the retaining member before the retaining member engages with the auxiliary material, staple cartridge, and / or anvil portion. Generally speaking, once firing is completed, the retaining member may be disengaged from the auxiliary material and / or end effector so that the auxiliary material may remain at the surgical site when the end effector is removed. This article refers to Figure 12-15 Some exemplary, non-limiting embodiments of retaining members are described.

[0095] Fig.12An exemplary embodiment of a connecting or retaining member 202 associated with an auxiliary material 200 to secure the material 200 at a temporary position relative to the lower jaw 52 of the end effector 50 is shown. As shown, the auxiliary material 200 is disposed on the staple cartridge 100 located in the elongated channel 56 of the lower jaw 52, ​​and the retaining member 202 extends therethrough. In an embodiment, the retaining member 202 is in the form of a single suture stitched through multiple locations of the auxiliary material 200, or it can be a plurality of sutures disposed at one or more locations on the auxiliary material 200. As shown, the sutures are positioned at locations around the periphery of the auxiliary material 200 and are also adjacent to a central longitudinal channel 201 formed in the auxiliary material 200. The channel 201 makes it easier for a blade to pass through the auxiliary material 200 to cut the material 200 into two or more separate strips. In some embodiments, for example when the retaining member 202 is a single suture that passes through multiple locations of the auxiliary material 200, a blade passing through the lower jaw 52 can cut the retaining member 202 at one or more locations, thereby separating the retaining member 202 from the auxiliary material 200 and removing it from the surgical site while the auxiliary material 200 is retained at the surgical site by one or more staples ejected from the magazine 100.

[0096] Fig.13 Another embodiment of a connecting or retaining member 202' is shown in association with the auxiliary material 200' to secure the material 200' at a temporary position on the end effector 50. The retaining member 202' has a Fig.12 The retaining member 202 of FIG. 5 is of similar construction to the retaining member 202 of FIG. 5 , however, in this embodiment, the retaining member 202 ′ is used to secure material to the anvil or upper jaw 54 rather than the cartridge or lower jaw 52 .

[0097] Fig.14 Another non-limiting embodiment of a connecting or retaining member 202" for releasably retaining an auxiliary material 200" to at least one of the upper jaw 54 and the lower jaw 52 is shown. In this embodiment, the retaining member 202" is a single suture that extends through the distal portion 200d" of the auxiliary material 200" and is connected to the proximal end 54p of the upper jaw 54. The terminal end 202t" of the retaining member 202" can be used to move the retaining member 202" relative to the jaws 54, 52. In its extended position (in Fig.14), the retaining member 202" may hold the auxiliary material 200" in place when the end effector 50 is inserted into the surgical site. Thereafter, the jaws 52, 54 of the end effector 50 may be closed onto tissue, for example, and staples from the staple cartridge 100 may be deployed through the auxiliary material 200" and into the tissue. The retaining member 202" may be moved into its retracted position so that the retaining member 202" may be operably disengaged from the auxiliary material 200". Alternatively, the retaining member 202" may be retracted before the staples are deployed. In any event, in view of the above, the end effector 50 may be opened and withdrawn from the surgical site, leaving behind the auxiliary material 200" and the tissue.

[0098] Fig.15 Another non-limiting embodiment of a connection or retaining member 202"' for securing an auxiliary material 200"' to a certain position of an end effector is shown. Specifically, the auxiliary material 200"' and the retaining member 202"' are connected to Fig. 9 and Fig.10 In this embodiment, the retaining member 202"' is in the form of a suture that is used to join the auxiliary material 200"' to the proximal end 52p' and the distal end 52d' of the first lower jaw 52'. Similarly, as Fig. 9 and 10 As shown, the auxiliary material 200'" can also be fixed to the proximal end 54p' and the distal end 54d' of the second upper jaw 54'. Optionally, a recess can be formed in either or both of the jaws 52', 54', and either or both of the auxiliary material 200'", which can protect the retaining member 202'" from unexpected cutting caused by external objects. In use, when the drive assembly passes through the end actuator 50' to release the auxiliary material 200'", the blade 81' on the drive assembly 80' can cut into the retaining member 202'".

[0099] Those skilled in the art will recognize that there are a variety of other methods by which the auxiliary material can be temporarily retained relative to the end effector. In various embodiments, the connecting or retaining member can be configured to be released from the end effector and deployed along the auxiliary material sheet. In at least one embodiment, the head portion of the retaining member can be configured to be separated from the main body portion of the retaining member so that the head portion can be deployed with the auxiliary material while the main body portion remains attached to the end effector. In other various embodiments, when the auxiliary material is disengaged from the end effector, the entirety of the retaining member can remain engaged with the end effector.

[0100] Tissue reinforcement materials with sealing properties

[0101] Tissue enhancement materials described herein can be embodied as a variety of different materials, including auxiliary materials. Although in various cases, auxiliary materials can be synthetic materials or biomaterials, in various embodiments, auxiliary materials include both synthetic materials and biomaterials (i.e., they are mixed auxiliary materials). The resulting combination can advantageously show the beneficial characteristics of two types of materials from a single mixed material. For example, mixed auxiliary materials can be designed to combine the benefits of biomaterials (such as improving healing and tissue growth) with the desired mechanical properties of synthetic materials (such as elasticity and the ability to provide compression). In various embodiments, synthetic materials can also provide structure and support (such as increasing strength and / or shear strength to fiber biomaterials) for biomaterials, while also allowing biomaterials to contact the surgical site and support and / or promote healing. In addition, mixed auxiliary materials can be configured to help reduce inflammation, promote cell growth, and / or otherwise improve healing. In various embodiments, auxiliary materials can be bio-implantable and / or bioabsorbable.

[0102] Figure 16-16C Several views of an exemplary tissue reinforcement material having a plurality of fibers arranged in a loop structure are shown.

[0103] Fig.16 and 16A An exemplary tissue reinforcement material 1601 according to the present disclosure is shown. Here, the tissue reinforcement material 1601 is releasably retained in a surgical stapler end effector (see FIG. 1602 ) partially shown through an anvil or upper jaw 1602. Figure 1 and 10 ) for delivery to the tissue when the nail is deployed. The tissue reinforcement material 1601 includes a plurality of fibers 1603, which have an arrangement configured to compress and seal around a fastening component (e.g., a surgical nail) inserted through the tissue reinforcement material. Those skilled in the art will appreciate that the benefits of the compression and sealing properties may be that they prevent fluids (e.g., blood) from leaking around the nail legs. In this example, the fiber arrangement is a ring structure, as further detailed in the enlarged fiber 1603'. The fibers 1603, 1603' form a ring structure by braiding the fibers 1603, 1603'.

[0104] Fig. 16B A single strand of fiber 1604 is shown in a loop structure. In this example, fiber 1604 is contacted with a liquid or gel and dried to form a film 1605 that surrounds fiber 1604 and extends between the loops in fiber 1604. Fig. 16C Shown along Fig. 16B16, wherein the fiber 1604 is embedded in the membrane 1605. The fiber 1604 may be braided or woven with other fibers or another portion of the same fiber 1604 to achieve the desired sealing properties.

[0105] Although Fig.16 and 16A The specific loop structure of fibers 1603, 1603' is shown, and Fig. 16B and 16C Specific single strands are shown, but those skilled in the art will appreciate that multiple fibers can be arranged into many alternative structures with the following arrangement: the arrangement is configured to compress and seal around the fastening components inserted through these fibers (which can also be the function of other characteristic structures or components of tissue reinforcement materials). The example of the alternative structure includes braids, interlocking and interconnecting patterns and different loop structures. Exemplary patterns can include two or more loops or braided structures. Similarly, patterns can include two or more types of fibers. The arrangement can be configured to stretch and recover the material in response to the penetration of the fastening components. Similarly, multiple fibers can be elastic. In various embodiments, the arrangement can advantageously provide a biomaterial (e.g., a woven bioproduct) with the mechanical properties of a desired synthetic material.

[0106] Fig.17A and 17B Exemplary fiber arrangements are shown, which are configured to compress and seal around fastening components (e.g., surgical staples) inserted through the fibers. In these examples, woven materials 1700, 1700' include multiple fibers 1701, 1701' with a braided loop structure arrangement. Dashed circles 1702, 1702' indicate the region through which fastening components (e.g., surgical staples) in woven materials 1700, 1700' are inserted. Those skilled in the art will recognize that although woven materials 1700, 1700' have a substantially uniform arrangement, alternative materials with different patterns (e.g., denser braids at the region through which fastening components are inserted) are also encompassed by the present disclosure. As shown, when fastening components such as legs 1703, 1703' are inserted through woven material 1700, 1700', the braiding in regions 1704, 1704' adjacent legs 1703, 1703' is twisted, such as by tightening and / or expanding, thereby sealing around legs 1703, 1703'.

[0107] Fig.17A and 17B It also illustrates that different types of fibers (e.g., in addition to different types of arrangements) may be used to achieve desired mechanical properties. For example, a textured fiber 1701' having a coarser texture is shown. Fig. 17B compared to, Fig.17A shows narrower filaments 1701. Therefore, Fig.17A Compared to the area 1704 adjacent to the nail leg 1703, Fig. 17B Regions 1704' in the vicinity of staple legs 1703' exhibit greater tension and / or expansion.

[0108] Those skilled in the art will recognize that Fig.17A and 17B The fiber arrangements shown in are non-limiting examples, and alternative materials with different fiber types and combinations are also encompassed by the present disclosure. In various embodiments, multiple fibers include biomaterials. In addition, in various embodiments, multiple fibers include synthetic materials. In some embodiments, multiple fibers include biomaterials and synthetic materials. The fiber can be woven, woven, cast or extruded.

[0109] Fig.18 Another exemplary embodiment 1800 of a tissue reinforcement material 1801 having vertical and radial elasticity is shown to seal around a fastener 1802 inserted through the material 1801 and tissue 1803 (e.g., biological tissue at a surgical site). Fig.18 As shown, tissue reinforcement material 1801 has been released from a portion of a surgical stapler end effector (not shown) and is delivered to tissue 1803 as staples 1802 from the surgical stapler (not shown) are deployed. As shown, tissue reinforcement material 1801 includes a plurality of fibers 1804 having an arrangement configured to compress and seal around fasteners 1802 inserted through the tissue reinforcement material.

[0110] Fig.16A -C and 17A-B, the fibers 1603, 1603', 1604, 1701, 1701' have a ring structure that is primarily deformed, tightened and / or expanded around the fastening component to seal around the fastening component. In contrast, Fig.18 The plurality of fibers 1804 shown in the figure have a three-dimensional network pattern, which has vertical elasticity 1805 and radial elasticity 1806, thereby sealing around the fastening component 1802 mainly by the fibers 1804 exerting elastic force and / or spring force on the fastening component 1802. The vertical elasticity 1805 and radial elasticity 1806 of the plurality of fibers 1804 can be the result of the arrangement of the fibers, the fiber material, or a combination thereof. It should be understood by those skilled in the art that other fiber arrangements that can exert elastic force and / or spring force on the fastening component are possible and are not limited to Fig.181000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 TM The elasticity is achieved by vertically standing rings made of a material such as POLYCAPRONE (available from Ethicon, Inc.) and the rest of the tissue reinforcement material can be made of biological or relatively soft materials such as POLYCAPRONE 25 (available under the trade name MONOCRYL TM The base of each upright loop can be knotted to the interwoven base to provide anchoring to provide more column force or resilience. In one embodiment, the upright fibers can also be woven in an inverted pattern with all other fibers at diagonals (e.g., plus and minus 30 degrees from vertical). In such a pattern, the alternating fibers can offset each other's deviation, which allows them to lie flat, supporting the upper woven structure with a trussed lower structure providing vertical resilience.

[0111] Fiber can be selected based on other physical properties.For example, in various embodiments, material expands around fastening components when fastening components are inserted through it, to form a seal around fastening components.In various embodiments, material expands around fastening components when second material is wetted, to form a seal around fastening components.In some embodiments, material expands around fastening components when fastening components are inserted through it and when material is wetted, to form a seal around fastening components.In addition, in various embodiments, material engages fastening components to alleviate the movement of materials and tissues of adjacent fastening components relative to fastening components when fastening components are inserted through it.Fiber and its arrangement can also provide tissue reinforcement materials with other properties such as flexibility, stretching and recovery ability and / or release or wash out one or more bioactive agents (such as medicine).Fiber can be or include biological fiber.It will be appreciated by those skilled in the art that material properties (such as about sealing) can be affected by the parts of materials other than fiber.

[0112] In various embodiments, the tissue augmentation material comprises a biological material. Likewise, the tissue augmentation material may comprise a synthetic material. In various embodiments, the tissue augmentation material may be formed as a single layer. For example, Fig.16In various embodiments, the material may have a single layer including multiple fibers. The single layer may include biomaterial and multiple fibers. In various embodiments, the tissue reinforcement material may be formed into two or more layers, for example, as shown in Figures 23 and 24. For example, the material may have a first layer including biomaterial and a second layer including multiple fibers. In various embodiments, the material is a mixed auxiliary material including biomaterial and synthetic material. It should be understood that the biomaterial (when present) may be in the form of fibers or other forms such as membranes.

[0113] The tissue augmentation material can be made of substantially any biomaterial and / or synthetic material having desired mechanical properties (e.g., sealing) and biological properties (e.g., bioimplantable and bioabsorbable). Representative examples are discussed in the above implantable material section. It should be understood by those skilled in the art that the shape of the tissue augmentation material (and / or its layers) is not limited to the parallelepiped or rhombohedral forms shown in the illustrated examples. In various embodiments, the hybrid auxiliary material (and / or its layers) need not be as Fig.16 and 18 , and may, for example, vary in thickness or have irregularly shaped portions.

[0114] As discussed above, Fig.16 The tissue reinforcement material 1601 is shown in the context of a staple cartridge assembly 1600 for use with a surgical stapler, which is another embodiment encompassed by the present disclosure. The assembly 1600 includes the tissue reinforcement material 1601 and a cartridge body having a plurality of staple cavities configured to receive staples therein (see, e.g., Figure 4 and 10 As discussed above, the tissue reinforcement material 1601 is releasably retained in the surgical stapler end effector (see Figure 1 and 10 ) (partially shown in this example by an anvil or upper jaw 1602) for delivery to tissue when the nail is deployed. The tissue reinforcement material 1601 includes a plurality of fibers 1603 having an arrangement (in this example, a ring structure) configured to compress and seal around a fastening component inserted through the tissue reinforcement material.

[0115] Here, the cartridge body and staples are closed by the lower jaw of the end effector of the surgical instrument (see, e.g. Figure 1 and 10 ). The tissue augmentation material 1601 is releasably retained on the anvil or upper jaw 1602 and is configured to be delivered to the tissue by deploying staples from the cartridge body (discussed below). As will be appreciated by those skilled in the art, Fig.16Many configurations other than the examples of are possible. For example, the tissue augmentation material may be releasably retained on a staple cartridge, both the staple cartridge and the upper jaw of the end effector, the lower jaw of the end effector, or both the upper jaw and the lower jaw of the end effector (see, e.g., Fig.24A -C).

[0116] The tissue reinforcement material can be releasably retained on a portion of the surgical stapler by a retaining member, which can have a variety of forms and configurations, such as one or more sutures, adhesive materials, staples, brackets, snap-on or other coupling or mating elements, etc. The retaining member is further discussed in detail in the retaining member section above. In various embodiments, the assembly includes at least one retaining member configured to couple the material to the cartridge body. At least one retaining member (which may include a suture) may be coupled to the outer edge of the cartridge body and the outer edge of at least one of the biological tissue membrane and the synthetic substrate layer.

[0117] In other aspects and embodiments, the present disclosure also provides a tissue reinforcement material that is releasably retained on a portion of an end effector of a surgical stapler for delivery to tissue when deploying staples, wherein the tissue reinforcement material has an arrangement (in addition to a loop structure of fibers) that is configured to compress and seal around a fastening component inserted through the tissue reinforcement material. Fig.19 A perspective view of one such alternative end effector component 1900 is shown, wherein the tissue reinforcement material 1901 comprises a collagen matrix. Fig.16 Similar to the implementation scheme, Fig.19 The tissue reinforcement material 1901 in the embodiment is releasably retained on the upper jaw 1902 of the end effector. However, as will be appreciated by those skilled in the art, Fig.19 Many configurations other than the examples of are possible. For example, the tissue augmentation material may be releasably retained on a staple cartridge, both the staple cartridge and the upper jaw of the end effector, the lower jaw of the end effector, or both the upper jaw and the lower jaw of the end effector (see, e.g., Fig.24A -C).

[0118] like Fig.19 As shown, tissue augmentation material 1901 includes a collagen matrix formed by molding and then hardening aqueous collagen. For example, collagen purification and refining processes can suspend the collagen in an aqueous state. In this state, oil and other impurities can be skimmed off, and the aqueous collagen can be poured into a mold. Fig.19 ,as well as Fig. 20As shown in the detailed cross-sectional view of FIG, the mold (not shown) has reverse dimples so that a solid collagen matrix 1901 with a basic anvil dimple shape 1903 is formed on the face 1905 of the matrix, and the dimple shape 1903 cooperates with a corresponding dimple 1904 on the upper jaw 1902 of the end effector. The temperature and surface conditions of the mold can be adjusted to produce density variations around these reverse dimple shapes 1903, and once hardened, the reverse dimple shapes 1903 can be embedded in the corresponding dimples 1904 on the anvil or upper jaw 1902 of the nail cartridge. Alternatively, a similar method can be used to form a tissue reinforcement material from a film of 65 / 35PGA / PCL, which can act as a semi-adhesive in the film. The amount of PGA / PCL left on the collagen after firing can be minimal.

[0119] When the tissue reinforcement material 1901 or a similar material is compressed against the tissue 1906 during clamping (i.e., between the upper jaw 1902 and the lower jaw 1908 of the end actuator), the main collagen body 1901 and the pits 1903 can be crushed to form a layer that can be easily penetrated by the nails 1907 (e.g., from the nail magazine 1909) but can expel the tissue 1906 from the nail forming area (e.g., the pits 1903), thereby minimizing damage to the tissue 1906 (e.g., blood vessels) by the nails and thereby minimizing bleeding after suturing.

[0120] Fig.21 A cross-section 2100 of a deployed tissue augmentation material is shown, wherein materials and methods such as Figure 16-20 Those shown may be modified by including a substance that swells in the presence of a liquid, such as a hydrogel, oxidized regenerated cellulose (ORC), etc. The swelling may help seal around the staple legs 2101 inserted through the tissue 2102 and tissue reinforcement material 2103 and help minimize tissue damage. Those skilled in the art will appreciate that such swelling materials may include or may be combined with other features and properties disclosed or discussed herein.

[0121] Fig. 22 An exemplary hybrid auxiliary tissue augmentation material 2201 is shown implanted at a surgical site 2200. Hybrid auxiliary materials such as material 2201 can advantageously combine the benefits of biological materials and synthetic materials. For example, a biological auxiliary matrix can produce a smaller inflammatory response (i.e., compared to a synthetic matrix) while retaining biological growth factors, chemical compounds, and / or hormones that can facilitate healing. However, at the micro level, the biological matrix, whether wet or dry, can be a fibrous structure that is not capable of providing an adequate mechanical seal (in demanding applications such as large vessel transection). Because the hybrid auxiliary material can have a structure for retaining tissue in the pit nail formation area (e.g., as combined with Fig. 20Hybrid adjunct materials such as material 2201 may, for example, reduce leakage or bleeding (e.g., in a transected and sutured vessel) due to the mechanical strength beyond that described herein and the ability to grip around the staple legs to limit bleeding through the holes formed by the staple legs and above the staple legs.

[0122] To illustrate the mechanical properties of hybrid adjunct material 2201, surgical site 2200 is shown with a first suture area 2202 having no tissue reinforcement material and a second suture area 2203 having hybrid adjunct material 2201. At first suture area 2202, first staple 2204 has been inserted through tissue 2205, thereby forming a hole 2206 through tissue 2205. Thus, blood loss 2207 may occur through the legs of staple 2204 and through the hole 2206 formed by the legs of staple 2204.

[0123] In contrast, at the second suture area 2203, the second nail 2208 has been inserted through tissue 2205 and hybrid auxiliary material 2201. As shown, hybrid auxiliary material 2201 includes a biological external tissue contact layer 2209, which can be thin, resilient and more elastic than pure biological fiber matrix. Hybrid auxiliary material 2201 also includes a synthetic second layer 2210, which is selected not necessarily for strength, rebound or other total mechanical reasons, but for micro-nail engagement reasons. In order to keep the benefits of biological layer 2209, thin synthetic layer 2210 includes a mesh or variable thickness layer that minimizes its interference in the contact between tissue 2205 and biological layer 2209. Synthetic layer 2210 forms a seal around the leg of the second nail 2208, and prevents or alleviates blood 2211 from leaking above the leg of the second nail 2208 through the hole 2212 formed by the leg of the second nail 2208. In various embodiments, the sealing properties of the hybrid auxiliary material can be generated by the braid of the ring structure, spring force or compression force, expansion, etc. It should be understood by those skilled in the art that alternative hybrid materials and hybrid auxiliary materials can also be used according to the present disclosure. For example, the synthetic layer 2210 can replace the biological material to provide a tissue reinforcement material with desired mechanical properties.

[0124] Fig.23A -C shows a different perspective view of an alternative exemplary tissue reinforcement material 2300. Similar to the tissue reinforcement materials discussed and exemplified above, the tissue reinforcement material 2300 can be releasably retained on a portion of the surgical stapler end effector for delivery to the tissue when the staples are deployed and can be sealed around the fastening components inserted through the tissue reinforcement material. Similarly, the tissue reinforcement material 2300 can be part of a staple cartridge assembly.

[0125] refer to Fig.23A, tissue reinforcement material 2300 includes a top layer 2301, a bottom layer 2302, and one or more supports 2303 having a surgical adhesive therein. The supports 2303 can be arranged in a pattern, for example, to fill a plurality of nail cavities configured to accommodate nails therein. That is, the supports 2303 can be aligned with the nail cavities so that the nails are deployed through and pierce the supports, and the surgical adhesive is sealed around the nails and punctures. Although supports are used in the embodiment of Figure 23, other arrangements for providing surgical adhesives can be used. For example, the surgical adhesive can be uniformly sandwiched between the top layer and the bottom layer or within the layer, or can be provided in a capsule on the surface of the top layer or the bottom layer (for example, with Fig.24A -C similar). Although the exemplary material shown in FIG. 23 uses a surgical adhesive, it should be understood that other materials / fluids / gels with suitable properties may be used in addition or alternatively.

[0126] Fig. 23B A side view of tissue augmentation material 2300 at buttresses 2303 is shown, including a top layer of buttresses 2304, a bottom layer of buttresses 2305, and a surgical adhesive 2306 disposed therebetween. Fig. 23B The legs of surgical staples 2307 are shown positioned to be deployed and piercing buttress 2303. The fluid / gel properties of the surgical adhesive can be retained when the surgical adhesive is sealed between the top layer of buttress 2304 and the bottom layer of buttress 2305. Similarly, the top layer 2304 and bottom layer 2305 can allow the surgical adhesive to flow and achieve a desired sealing effect after suturing. Fig.23C 23 is an isometric view of tissue augmentation material 2300 after deployment of staples 2308 that penetrate buttress 2303. As shown, surgical adhesive 2306 is sealed around staples 2308 and penetrates into the buttress.

[0127] As with the adjunct materials and hybrid adjunct materials, the top layer 2301 and bottom layer 2302 may include substantially any of the biological and synthetic layers, absorbable polymers / polymer blends, gelatin, films, and matrices disclosed and described herein. In various embodiments, the surgical adhesive acts as a mechanical structure that seals around the fastening components (e.g., staple legs) and prevents leakage (e.g., blood, air, GI fluids, etc.) at the surgical site. In addition, the tissue reinforcement material 2300 may provide reinforcement and / or additional strength to the tissue at the surgical site.

[0128] Examples of materials suitable for the top and / or bottom layers include, but are not limited to, PLLA, PLGA, PCL, PGA, TMC, and associated copolymers. Examples of suitable materials / fluids / gels or surgical adhesives include, but are not limited to, bioactives (e.g., freeze-dried fibrin / thrombin powder, freeze-dried fibrin / thrombin on short fiber vicryl filaments and / or ORC matrix), inert actives (e.g., ORC fibers in PCL / PGA liquid), viscous absorbables (e.g., 65 / 35PCL / PGA, 50 / 50PCL / PGA, 50 / 50PLLA / PCL, etc.), viscous urethane gels, and gel-like absorbables (e.g., blends of copolymers or isomers). Examples of suitable membrane materials include, but are not limited to, PLLA, PLGA, PCL, PGA, TMC, associated copolymers, etc.

[0129] Fig.24A -C shows another alternative exemplary tissue augmentation material including a surgical adhesive that seals around a fastening component.

[0130] refer to Fig.24A , the first tissue reinforcement material 2401 is releasably retained on the anvil 2402 portion of the surgical stapler end effector 2400 for delivery to the tissue when the nail is deployed, thereby sealing around the fastening component inserted through the tissue reinforcement material. The first tissue reinforcement material 2401 includes a first top layer 2403, a first bottom layer 2404, and a first surgical adhesive 2405 disposed therein. The anvil 2402 defines a plurality of dimples 2406, which correspond to a plurality of first mating dimple-shaped features 2407 defined by the first tissue reinforcement material 2401 and encapsulating the first surgical adhesive 2405. In various embodiments, the plurality of dimples 2406 and the corresponding plurality of mating dimple-shaped features 2407 (at least partially) mediate the releasable retention of the material 2401 on the anvil 2402.

[0131] The second tissue reinforcement material 2411 is releasably retained on the staple cartridge 2412 of the surgical stapler end effector 2400 for delivery to the tissue when the staples are deployed, thereby sealing around the fastening component inserted through the tissue reinforcement material. The second tissue reinforcement material 2411 includes a second top layer 2413, a second bottom layer 2414, and a second surgical adhesive 2415 disposed therein. The staple cartridge 2412 defines a plurality of dimples 2416, which correspond to a plurality of mating dimple-shaped features 2417 defined by the second tissue reinforcement material 2411 and encapsulating the second surgical adhesive 2415. In various embodiments, the plurality of dimples 2416 and the corresponding plurality of second mating dimple-shaped features 2417 (at least partially) mediate the releasable retention of the material 2411 on the staple cartridge 2412. The staple cartridge 2412 has a plurality of staple cavities 2418 configured to be able to place staples 2419 therein.

[0132] Fig. 24B An exploded view of a portion of the anvil 2402 assembly and the staple magazine 2412 is shown, providing additional details regarding various feature structures of a portion of the surgical stapler end actuator 2400, particularly the pits 2406, 2416, the corresponding multiple mating pit-shaped feature structures 2407, 2417 and their relative positioning with respect to the staple 2419.

[0133] Fig.24C Shows the above combination Fig.24A and 24B An isometric view of the first tissue reinforcement material 2401 and the second tissue reinforcement material 2411. This view focuses on the features of the first top layer 2401 and the second top layer 2413, namely, the first plurality of matching dimple-shaped features 2407 and the second plurality of matching dimple-shaped features 2417. Fig.24C , the second tissue augmentation material 2411 is shown as a partial cross-sectional view to illustrate the relative positioning of the plurality of second mating dimple-shaped features 2417 .

[0134] Those skilled in the art will appreciate that by changing Fig.24A -C to provide various additional embodiments according to the present disclosure. Fig.24A Various representative compositions and configurations for use with the embodiments in -C are discussed in the above detailed description and exemplary embodiments.

[0135] Fig.24A-C shows two membrane layers 2403, 2404 and 2413, 2414, where the capture material 2405, 2415 (e.g., surgical adhesive) can be viscous and / or reactive with body fluids to seal around a needle-like nail 2419 in a rubber gasket. The viscous fluid can fill the defects and / or tears in the membrane layers 2403, 2404, 2413, 2414 created by the legs of the nail 2419. The material 2405, 2415 can be a biological product such as fibrin, thrombin, calcium alginate, or cellulose (e.g., ORC or oxidized regenerated cellulose, which is a fiber in its solid non-reactive form). The material 2405, 2415 can also be an absorbable synthetic, such as 50 / 50 PCL / PGA or 70 / 30 PCL / PGA, which remains as a viscous fluid or semi-solid at body temperature.

[0136] In another aspect, the present disclosure provides a method for implanting a tissue augmentation material.

[0137] In another aspect, the present disclosure provides methods for implanting a tissue augmentation material. Fig.25A An example of one such method is shown in Figure 3-C. However, it should be understood that this and other methods provided by the present invention are applicable to the use of essentially any sealed tissue augmentation material according to the present invention.

[0138] Fig.25A The engagement of tissue 2500 between the lower jaw 2501 and the anvil or upper jaw 2502 of the surgical stapler at the surgical site is shown. At least one of the lower jaw 2501 and the upper jaw 2502 has a tissue reinforcement material 2503 releasably retained thereon. In this example, the lower jaw 2501 (e.g., by a cartridge assembly 2504) has a tissue reinforcement material 2503 releasably retained thereon. The material 2503 includes a plurality of fibers having an arrangement capable of compressing and sealing around a fastening member inserted through the tissue reinforcement material (see, e.g., Figure 16-18 as well as Figure 19-2 4). Here, tissue 2503 is engaged between an anvil or upper jaw 2502 and a lower jaw 2501 which encloses a cartridge assembly 2504 having staples 2505 disposed therein.

[0139] Fig.25B An actuated surgical stapler is shown that causes staples 2505 to be ejected from cartridge body 2504 and into biological tissue 2500. Staples 2505 extend through tissue reinforcement material 2503 to hold material 2503 at the surgical site. In this example, the actuated surgical stapler also cuts tissue 2503 at the surgical site between staples 2505, as shown in FIG. Fig.25BAs shown. Additional embodiments and examples of such cutting embodiments are described above. However, the present disclosure also contemplates embodiments in which tissue is not necessarily cut, or in which cutting tissue and actuating the surgical stapler are not necessarily performed simultaneously.

[0140] Fig.25C The tissue 2500 after the deployment of nail 2505 and tissue reinforcement material 2503 is shown. As shown, nail 2505 extends through tissue reinforcement material 2503 and tissue 2500 to keep material 2503 at the surgical site. In this example, the tissue 2500 including nail 2505 is sealed and enhanced by material 2503, so as to prevent or alleviate tearing, fluid (such as blood) leakage or other undesirable damage to the surgical site. In various embodiments, only material is required to form a seal around the fastening component (such as, nail leg). Avoiding undesirable damage can reduce the surgical recovery time and alleviate surgical complications. In addition, the enhancement produced by the biomatrix of material 2503 and / or the effect of the bioactive compound therein can promote healing. Similarly, because any such synthetic can be internal to biological tissue membrane or matrix and / or the synthetic does not contact tissue 2500 substantially, the stimulation and inflammation from synthetic materials can be prevented or alleviated by enhancing. In an alternative embodiment, substantially all synthetic materials can be encapsulated by biomaterials to prevent or alleviate stimulation and inflammation from synthetic materials.

[0141] The tissues disclosed herein can be designed to be discarded after a single use, or they can be designed to be used multiple times. However, in either case, the device can be used again after being repaired after at least one use. Re-repairing can include any combination of the following steps: disassembling the device, then cleaning or replacing specific parts, and subsequently reassembling. Specifically, the device can be disassembled, and any number of specific parts or components of the device can be selectively replaced or removed in any combination, such as electrodes, batteries or other power sources, external wear-resistant sensors and / or their housings, etc. After cleaning and / or replacing specific parts, the device can be reassembled on a repair device or by a surgical team immediately before a surgical operation for subsequent use. Those skilled in the art will appreciate that the re-repair of the device can utilize a variety of techniques for disassembly, cleaning / replacement and reassembly. The uses of these technologies and the re-repaired devices obtained are all within the scope of the present invention.

[0142] In some embodiments, the devices described herein can be processed before surgery. First, new or used instruments are obtained and cleaned as needed. The instruments are then sterilized. In one sterilization technique, the instruments are placed in a closed and sealed container, such as a plastic or TYVEK bag. The container and instruments are then placed in a radiation field that can penetrate the container, such as gamma radiation, X-rays, or high-energy electron radiation. The radiation kills bacteria on the instruments and in the container. The sterilized instruments are then stored in a sterile container. The sealed container keeps the instruments sterile until the container is opened in a medical facility.

[0143] Additional exemplary structures and components are described in the following U.S. applications: ____[100873-640 / END7353USNP] entitled “Hybrid Adjunct Materials For Use In Surgical Stapling,” ____[100873-641 / END7353USNP] entitled “Positively Charged Implantable Materials and Methods of Forming the Same,” ____[100873-642 / END7355USNP] entitled “Tissue Ingrowth Materials And Method Of Using The Same,” and ____[100873-643 / END7356USNP] entitled “Hybrid Adjunct Materials For Use In Surgical Stapling,” all of which were filed on the same day as the present application and are incorporated herein by reference.

[0144] According to the above-mentioned embodiments, those skilled in the art should be aware of the other features and advantages of the present invention. Therefore, the present invention should not be limited by the content specifically shown and described, unless the attached claims indicate otherwise. All publications and references cited herein are expressly incorporated herein by reference in their entirety.

Claims

1. A tissue reinforcement material that is releasably retained on a portion of an end effector of a surgical stapler for delivery to tissue when deploying staples, the tissue reinforcement material comprising a plurality of fibers having an arrangement configured to compress and seal around a fastening component inserted through the tissue reinforcement material, the tissue reinforcement material comprising a tissue contact layer that contacts the tissue and contains a biological material, and a synthetic layer that is located outside the tissue contact layer and is thinner than the tissue contact layer and contains a synthetic material, wherein the synthetic layer forms a mechanical seal around the fastening component, and wherein the synthetic layer has a mesh structure or a variable thickness structure.

2. The tissue augmentation material of claim 1, wherein the portion of the surgical stapler end effector comprises at least one of a staple cartridge and an anvil.

3. The tissue augmentation material of claim 1, wherein the material engages the fastening members when the fastening members are inserted therethrough to mitigate movement of material and tissue adjacent the fastening members relative to the fastening members.

4. The tissue augmentation material of claim 1, wherein the fastening components comprise staple legs.

5. A staple cartridge assembly for use with a surgical stapler, comprising: a cartridge body having a plurality of staple cavities configured to receive staples therein; as well as a tissue augmentation material releasably retained on a cartridge body and deliverable to tissue by deployment of the staples in the cartridge body, the tissue augmentation material comprising a plurality of fibers having an arrangement configured to compress and seal around a fastening member inserted therethrough; The tissue reinforcement material includes a tissue contact layer that contacts the tissue and contains a biological material, and a synthetic layer that is located outside the tissue contact layer and is thinner than the tissue contact layer and contains a synthetic material, wherein the synthetic layer forms a mechanical seal around the fastening component, and wherein the synthetic layer has a mesh structure or a variable thickness structure.